(162 days)
Not Found
No
The description focuses on the physical characteristics and intended use of a central venous catheter, with no mention of software, algorithms, or data processing that would indicate AI/ML.
No.
The document states that the device is for "infusion, intravenous therapy, blood sampling and for power injection of contrast media", which are diagnostic and procedural support functions rather than therapeutic.
No
The device is a central venous catheter used for infusion, intravenous therapy, blood sampling, and power injection of contrast media, not for diagnosing medical conditions.
No
The device description clearly states it is a family of central venous catheters made of radiopaque polyurethane tubing, which are physical hardware components.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly describes the device as being used for direct access to the central venous system for infusion, therapy, blood sampling, and power injection of contrast media. These are all procedures performed on the patient, not on a sample of bodily fluid or tissue outside the body for diagnostic purposes.
- Device Description: The description details a catheter designed for insertion into a vein. This is a therapeutic and procedural device, not a device used to analyze samples.
- Lack of Diagnostic Function: There is no mention of the device being used to analyze or test any biological samples to diagnose a condition.
IVD devices are specifically designed to examine specimens derived from the human body (like blood, urine, tissue) to provide information for diagnostic, monitoring, or compatibility purposes. The ORION™ II CT CVC does not fit this description.
N/A
Intended Use / Indications for Use
The ORION™ II CT CVC is intended to be used by medical professionals for short-term access to the central venous system for infusion, intravenous therapy, blood sampling and for power injection of contrast media. All ORION™ II CT CVC products have a maximum · recommended infusion rating of 5 ml/sec.
The ORION™ II CT CVC is indicated for short term (less than 30 days) access to the central venous system for intravenous administration of fluids, medications, blood products, and/or nutritional therapy solutions when prescribed. Blood sampling and power injection of contrast media may also be conducted with the ORION™ III CT CVC.
Product codes (comma separated list FDA assigned to the subject device)
FOZ
Device Description
The ORION™ II CT CVC is a family of central venous catheters designed to perform infusion, intravenous therapy, blood sampling and also power injection of contrast media studies, The catheters, made of radiopaque polyurethane tubing, are inserted in a central vein. Each ORION™ II CT CVC has a kink resistant, gradual tapered catheter design. The ORION™ II CT CVC kit includes a catheter and introduction components. The catheter is supplied sterile and non-pyrogenic in a variety of kit configurations.
The ORION™ II CT CVC is indicated for dwell times shorter than 30 days. The ORION™ II CT CVC catheter assemblies have been tested to withstand power injection of worst-case viscosity injection media at 5 ml/sec with a maximum power injector pressure of 300 psi.
The ORION™ II CT CVC product line has catheters in 16 G single lumen, 5 Fr and 7 Fr dual lumen and 7 Fr triple lumen. Catheters range from approximately 13-30 cm long. The catheters are attached to an injection-molded polyurethane hub that has extension legs with Luer lock fittings for access attachment. All ORION™ II CT CVC products have a maximum recommended infusion rating is 5 ml/sec. The maximum pressure or pounds per square inch (psi) of the power injector utilized should not exceed 300 psi.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
central venous system
Indicated Patient Age Range
Not Found
Intended User / Care Setting
medical professionals
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Verification testing was performed according to protocols based on the above-referenced guidance document recommendations and additional standards.
Performance data gathered in design verification testing demonstrated that the ORION™ II CT CVC is substantially equivalent to the noted predicate device.
The ORION™ II CT CVC met all established acceptance criteria for performance testing and design verification testing. This testing demonstrated that the ORION™ II CT CVC is safe and effective for its intended use, and based on FDA's decision tree is substantially equivalent to the following predicate device: SYNERGY™ CT PICC (K101329).
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 880.5200 Intravascular catheter.
(a)
Identification. An intravascular catheter is a device that consists of a slender tube and any necessary connecting fittings and that is inserted into the patient's vascular system for short term use (less than 30 days) to sample blood, monitor blood pressure, or administer fluids intravenously. The device may be constructed of metal, rubber, plastic, or a combination of these materials.(b)
Classification. Class II (performance standards).
0
Page 15 of 144
Health Line International Corporation
510(k) Premarket Notification Submission: ORION™ II CT CVC
MAY 1 8 2012
510(k) SUMMARY OF SAFETY AND EFFECTIVENESS (21 CFR 807.92) for ORION™ II CT CVC
SUBMITTER:
Health Line International Corporation 803 N. 1250 W. - STE 1 Centerville, Utah 84014
ESTABLISHMENT REGISTRATION NUMBER: 3006097687
CONTACT:
Nola L. Benstog QA/RA Director Telephone: 801-773-7798 Fax: 801-820-8007 Email: nbenstog@hlic.net
DATE PREPARED:
November 30, 2011
NAME OF MEDICAL DEVICE:
Proprietary Name: Regulation Name: Common/Usual Name: ORION™ II CT CVC Intravascular Catheter Central Venous Catheter (CVC), single, double and triple lumen
DEVICE CLASSIFICATION:
Classification Panel: Regulatory Class: Product Code: Regulation Number:
General Hospital Class II FOZ 21 CFR 880.5200
PREDICATE DEVICE:
Proprietary Name: Regulation Name: Common/Usual Name: Classification Panel: Regulatory Class: Product Code: Regulation Number:
SYNERGY™ CT PICC (K101329)
Percutaneous, Implanted, Long-term Intravascular Catheter Catheter, Intravascular, Therapeutic, Long Term General Hospital Class II । ਹਵ 21 CFR 880.5970
CONFIDENTIAL
1
DEVICE DESCRIPTION:
The ORION™ II CT CVC is a family of central venous catheters designed to perform infusion, intravenous therapy, blood sampling and also power injection of contrast media studies, The catheters, made of radiopaque polyurethane tubing, are inserted in a central vein. Each ORION™ II CT CVC has a kink resistant, gradual tapered catheter design. The ORION™ II CT CVC kit includes a catheter and introduction components. The catheter is supplied sterile and non-pyrogenic in a variety of kit configurations.
The ORION™ II CT CVC is indicated for dwell times shorter than 30 days. The ORION™ II CT CVC catheter assemblies have been tested to withstand power injection of worst-case viscosity injection media at 5 ml/sec with a maximum power injector pressure of 300 psi.
The ORION™ II CT CVC product line has catheters in 16 G single lumen, 5 Fr and 7 Fr dual lumen and 7 Fr triple lumen. Catheters range from approximately 13-30 cm long. The catheters are attached to an injection-molded polyurethane hub that has extension legs with Luer lock fittings for access attachment. All ORION™ II CT CVC products have a maximum recommended infusion rating is 5 ml/sec. The maximum pressure or pounds per square inch (psi) of the power injector utilized should not exceed 300 psi.
2
INTENDED USE:
The ORION™ II CT CVC is intended to be used by medical professionals for short-term access to the central venous system for infusion, intravenous therapy, blood sampling and for power injection of contrast media. All ORION™ II CT CVC products have a maximum · recommended infusion rating of 5 ml/sec.
INDICATIONS FOR USE:
The ORION™ II CT CVC is indicated for short term (less than 30 days) access to the central venous system for intravenous administration of fluids, medications, blood products, and/or nutritional therapy solutions when prescribed. Blood sampling and power injection of contrast media may also be conducted with the ORION™ III CT CVC.
TECHNOLOGICAL COMPARISON TO PREDICATE DEVICES:
New device is compared to Marketed Device? Yes. It is compared to a legally marketed predicate.
Does the new device have the same indication statements? Yes, with the exception of the insertion site and the removal of the long term access indication. Additionally, the ORION™ II CT CVC indications contain solutions detail for the CVC device.
Do the differences alter the intended therapeutic/diagnostic/etc. effect (i.e. deciding may consider impact on safety and effectiveness)? No.
Does the new device have the same technological characteristics, e.g. design, material, etc.? Yes. The CVC device of this submission, the ORION™ II CT CVC, is identical to that of (K101329), SYNERGY™ CT PICC, with the exception of the length. In fact, the ORION™ II CT CVC and the SYNERGY™ CT PICC are manufactured by the same company, Health Line International Corporation, the submitter of this submission. The basic fundamental scientific technology of the device has not changed. There may be minor variations in the contents of the introduction kit components.
Could the new characteristics affect safety or effectiveness? No.
Do the new characteristics raise new types of safety and effectiveness questions? No. There are no new types of safety and effectiveness questions.
Do accepted scientific methods exist for assessing effects of the new characteristics? Yes.
CONFIDENTIAL
3
Health Line International Corporation 510(k) Premarket Notification Submission: ORION™ II CT CVC
The FDA's Guidance on Premarket Notification [510(k)] Submission for Short-Term and Long-Term Intravascular Catheters, dated 3/16/95 was used to determine the appropriate methods for evaluating the device's performance.
Sterilization requirements of ISO 11135-1:2007, Sterilization of Health Care Products – Ethylene Oxide – Part 1: Requirements for Development, Validation and Routine Control of a Sterilization Process for Medical Devices.
Biocompatibility requirements according to of ISO-10993, Biological Evaluation of Medical Devices Part 1: Evaluation and Testing. Test profiles for externally communicating, bloodcontacting, prolonged contact devices will be met.
These and other standards were used to determine the appropriate methods for evaluating the device's performance.
Are performance data available to assess effects of new characteristics? Yes. Verification testing was performed according to protocols based on the above-referenced guidance document recommendations and additional standards.
Do performance data demonstrate equivalence? Yes. Performance data gathered in design verification testing demonstrated that the ORION™ II CT CVC is substantially equivalent to the noted predicate device.
CONCLUSION
The ORION™ II CT CVC met all established acceptance criteria for performance testing and design verification testing. This testing demonstrated that the ORION™ II CT CVC is safe and effective for its intended use, and based on FDA's decision tree is substantially equivalent to the following predicate device: SYNERGY™ CT PICC (K101329).
4
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/4/Picture/1 description: The image shows the seal of the U.S. Department of Health & Human Services. The seal features a stylized caduceus-like symbol with three intertwined lines, representing health and medicine. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" is arranged in a circular pattern around the symbol.
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
Ms. Nola Benstog OA/RA Director Health Line International Corporation 803 North 1250 West, Suite 1 Centerville, Utah 84014
MAY 1 8 2012
Re: K113622
Trade/Device Name: ORION™ II CT CVC Regulation Number: 21 CFR 880.5200 Regulation Name: Catheter, Intravascular, Therapeutic, Short Term Regulatory Class: Class II Product Code: FOZ Dated: April 24, 2012 Received: April 25, 2012
Dear Ms. Benstog:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
5
Page 2- Ms. Benstog
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices /ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours.
Antion D. anan
Anthony D. Watson, B.S., M.S., M.B.A. Director Division of Anesthesiology. General Hospital Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
6
Page 13 of 144
Health Line International Corporation Health Line Tricer Hiter Hitscion Submission: ORION™ II CT CVC
Indications For Use
510(k) Number (if known):
Device Name: ORION™ II CT CVC
Indications For Use:
The ORION™ II CT CVC is indicated for short term (less than 30 days) access to the central The ORION" II CT CVC In Indicated for short confinent medications, blood products, and/or
venous system for intravenous administration of fluids, medication of venous system for intravellous auministruction of hands sampling and power injection of
nutritional therapy solutions when prescribed. Onloary II CT CVC nutritional therapy solutions and the ORION™ II CT CVC.
contrast media may also be conducted with the ORION™ III CT CVC.
Prescription Use _ × (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use _ (21 CFR 807 Subpart C)
(Please do not WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Rld Clyn 5/17/12
I Vision Sion-Off) ·sion of Anesthesiology, General Hospital lection Control, Dental Davices
510(k) Number: K113622